Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Sets November Date For Pulse Oximeter Accuracy Meeting

Executive Summary

The US agency will hold an advisory panel meeting on 1 November to discuss ongoing concerns that pulse oximeters may be less accurate in people with darker skin.

You may also be interested in...



FDA Plans Meeting On Pulse Oximeter Accuracy

US regulators plan to hold a public meeting later this year to address concerns the devices are less accurate for people with darker skin tones.

UK Government Points At Oximeters For Contributing To Disparity In COVID-19 Outcomes

Sajid Javid, the UK’s secretary of state for health and social care, wants to collaborate with the US Department of Health and Human Services to investigate biases in monitoring and diagnostic devices.

Pulse Oximeters May Be Less Accurate For Dark-Skinned People, FDA Warns

The US agency’s safety alert says the devices, which measure blood oxygen levels, may be less accurate in patients with darker skin tones.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT145837

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel